Filing Details

Accession Number:
0001415889-21-001451
Form Type:
4
Zero Holdings:
No
Publication Time:
2021-03-11 19:12:31
Reporting Period:
2021-03-09
Accepted Time:
2021-03-11 19:12:31
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1604821 Natera Inc. NTRA Services-Medical Laboratories (8071) 010894487
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1697362 Burkes Michael Brophy C/O Natera, Inc.
13011 Mccallen Pass Building A Suite 100
Austin TX 78753
Chief Financial Officer No No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2021-03-09 3,021 $0.00 59,058 No 4 M Direct
Common Stock Acquisiton 2021-03-09 12,500 $0.00 71,558 No 4 M Direct
Common Stock Disposition 2021-03-10 5,954 $97.31 65,604 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Unit Disposition 2021-03-09 3,021 $0.00 3,021 $0.00
Common Stock Restricted Stock Unit Disposition 2021-03-09 12,500 $0.00 12,500 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
12,084 No 4 M Direct
12,500 No 4 M Direct
Footnotes
  1. Each Restricted Stock Unit ("RSUs") represents a contingent right to receive one share of the common stock of the issuer.
  2. The sale of shares was effected in order to satisfy tax withholding and remittance obligations in connection with the vesting of RSUs pursuant to Rule 10b5-1.
  3. The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.31 to $97.4456 per share, inclusive. The holder undertakes to provide, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
  4. The RSUs vest over four years. 25% of the RSUs vested on March 9, 2019 and the remaining shares vest in 12 equal quarterly installments thereafter.
  5. On March 22, 2019, the Reporting Person was granted RSUs covering 100,000 shares of common stock, which vests in tranches upon the Reporting Person achieving certain milestones relating to a combination of the passage of time and the Reporting Person achieving certain milestones relating to the Issuer's stock price. On March 9, 2021, the criteria was satisfied for the vesting of RSUs covering 12,500 shares of common stock.